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Abstract.  SV-40 T antigen  (TAg), human K-ras  v~12, 
and a dominant negative mutant of human p53 
(p53  ~a143) have been expressed singly and in all possi- 
ble combinations in postmitotic enterocytes distributed 
throughout the duodenal-colonic axis of 1-12-too-old 
FVB/N transgenic  mice to assess the susceptibility of 
this lineage to gene products implicated in the patho- 
genesis of human gut neoplasia.  SV-40 TAg produces 
re-entry into the cell cycle. Transgenic pedigrees that 
produce K-ras  wt2 alone, p53  Atal43 alone, or K-ras  v~12 
and p53  ~43 have no detectable phenotypic abnormali- 
ties.  However, K-ras  v~2 cooperates with SV-40 TAg to 
generate marked proliferative and dysplastic changes 
in the intestinal epithelium.  These abnormalities do 
not progress to form adenomas or adenocarcinomas 
over a 9-12-mo period despite sustained expression of 
the transgenes.  Addition of p53  Ala143 to enterocytes that 
synthesize SV-40 TAg and K-ras v~12 does not produce 
any further changes in proliferation or differentiation. 
Mice that carry one, two, or three of these transgenes 
were crossed to animals  that carry Min, a  fully 
penetrant,  dominant mutation of the Apc gene as- 
sociated with the development of multiple small intes- 
tinal and colonic adenomas.  A  modest (2-5-fold) in- 
crease in tumor number was noted in animals  which 
express SV-40 TAg alone, SV-40 TAg and K-ras  v~12, or 
SV-40 TAg,  K-ras  v~12 and p53  Ata143. However, the histo- 
pathologic features of the adenomas were not altered 
and the gut epithelium located between tumors ap- 
peared similar to the epithelium of their single trans- 
genic, bi-transgenic,  or tri-transgenic  parents without 
Min. These results suggest that (a) the failure of the 
dysplastic gut epithelium of SV-40 TAg X  K-ras  v~tt2 
mice to undergo further progression to adenomas or 
adenocarcinomas is due to the remarkable protective 
effect of a continuously and rapidly renewing epithe- 
lium,  (b) initiation  of tumorigenesis in Min mice typi- 
cally occurs in crypts rather than  in villus-associated 
epithelial cell populations,  and (c) transgenic mouse 
models of neoplasia involving members of the entero- 
cytic lineage may require that gene products impli- 
cated in tumorigenesis be directed to crypt stem cells 
or their immediate descendants.  Nonetheless, directing 
K-ras  vaIl2 production to proliferating and nonproliferat- 
ing cells in the lower and upper half of small intesti- 
nal and colonic crypts does not result in any detect- 
able abnormalities. 
T 
HE mouse intestinal  epithelium  represents  an attrac- 
tive model system for examining how cellular prolifer- 
ation,  lineage allocation  (commitment),  and differen- 
tiation  are normally regulated  and how they are distorted 
during development of neoplasia.  This is because prolifera- 
tion and differentiation  occur rapidly,  continuously,  and in 
a geographically  well-organized  fashion  in this organ.  The 
proliferative  unit of the gut epithelium is the crypt of Lieber- 
kiihn.  Each  small  intestinal  and  colonic  crypt  contains 
350-500 cells (81) and is supplied by a single active multipo- 
tent stem cell functionally  anchored near its base (30).  The 
descendants of this stem cell undergo several rounds of cell 
division,  creating  a transit cell population.  Approximately 
60% of crypt epithelial cells pass through the cell cycle every 
12 h (58). At some point during this series of amplifying di- 
visions,  cells  are  allocated to  one of four lineages.  The 
differentiation  programs of these lineages  are subsequently 
expressed during an orderly bipolar migration.  In the small 
intestine,  Paneth  cells differentiate  as they migrate to the 
base of each crypt where they reside for '~3 wk (11). Entero- 
cytes, goblet, and enteroendocrine cells differentiate as they 
migrate upward in vertical, coherent bands from each mono- 
clonal crypt to an adjacent villus (67).  Once cells reach the 
apical extrusion  zone of the villus,  they are exfoliated into 
the gut lumen. Enterocytes,  the principal  epithelial cell lin- 
eage,  complete their migration,  differentiation/maturation, 
and exfoliation in 2-3 d (9, 81). Colonic crypts in adult mice, 
like  small  intestinal  crypts,  are  monoclonal  (31). The 
proliferative  capacities of colonic and small intestinal crypts 
are similar  (i.e., 6-21 new cells/h/crypt versus 12 cells/h/ 
crypt) (73).  Cells exit colonic crypts to a hexagonal-shaped 
cuff of surface epithelial cells which is the colonic homolog 
of the small  intestinal  villus (67). 
A central question in gut epithelial cell biology is whether 
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ages  is  more  dependent  on  cellular  position  along  the 
crypt-villus (or crypt-surface epithelial cuff) axis or on the 
time that has elapsed since exiting the cell cycle. Studies of 
interspecies or heterotopic epithelial-mesenchymal recom- 
binants suggest that reciprocal permissive and instructive in- 
teractions occur between fetal gut endoderm and mesoderm 
which can influence differentiation of epithelial cells (39- 
41).  The  importance  of  mesenchymal-stromal-epithelial 
cross talk in regulating the proliferation and/or differentia- 
tion programs of gut epithelial cell lineages in adult mice re- 
mains uncertain. However, the existence of such interactions 
could allow for maintenance of  a lineage's differentiation  pro- 
gram despite alterations in proliferation or in the rate of cell 
migration. 
SV-40 T antigen (TAg) t and its mutant derivatives repre- 
sent powerful tools for exploring the contribution of certain 
regulators  of the  cell  cycle such  as  p53  and the  retino- 
blastoma susceptibility gene product (pRB) to the prolifera- 
tive state of a given cell lineage (8).  A  recent analysis of 
transgenic mice that carry intestinal fatty acid binding pro- 
tein (I-FABP)/SV-40  TAg fusion genes indicated that initia- 
tion of transgene expression in postmitotic, villus-associated 
enterocytes results in their re-entry into the cell cycle (34). 
The nature of the cell cycle is different from that observed 
in crypts where the transgene is not expressed. DNA synthe- 
sis proceeds more slowly in differentiated villus-associated 
enterocytes. Villus enterocytes may also have difficulty  pass- 
ing through the G2/M boundary (34). 
Production  of  SV-40 TAg  can  be  used  to  determine 
whether re-entry of enterocytes into the cell cycle changes 
their state of differentiation. Although analysis of the pat- 
terns of expression of several genes failed to disclose any 
such changes (34),  migration and exfoliation of SV-40 TAg- 
producing enterocytes may occur too rapidly to allow de- 
differentiation to occur or to be detected. Alternatively, the 
niche occupied by these cells (e.g., as defined by the underly- 
ing stroma and mesenchyme) may promote maintenance of 
the differentiated state and preclude dedifferentiation. We 
have explored these issues further by expressing gene prod- 
ucts implicated in initiation and/or progression of human 
colonic neoplasia,  singly and in various combinations, in 
villus-associated enterocytes. Analysis of these transgenic 
mice has  provided information about the effects  of these 
oncogenes on enterocytic proliferation/differentiation pro- 
grams and about the requirements for progression of tumori- 
genesis in this organ. 
Materials and Methods 
Construction of FABP/Oncogene DNAs 
Production of I-FABP  -tITs to +2S/SV_40 TAg (nueleotides 5235  to 2533) is 
described in Hauft el al. (34) (see Fig.  1 A). 
L.FABP-S~  to  +21/g.rosVaIl2  '  I.FABP-HTs  to  +2s/K_raseaal2  '  and 
I-FABP  -~s¢ to  +2s/K-rasYOll2,  A  l.l-kb PstI-BamHI fragment, containing 
the coding  sequence from the  K-ras  vm2  oncogene,  was  released from 
pSWll-1  (51).  pLF/SV-40/Bluescript (33)  contains nucleotldes -596 to 
+21 of the rat liver fatty acid binding protein gene (Fabpl) (72) linked to 
a 0.9-kb fragment containing SV-40 early splice and late polyadenylation 
signals (26). The Pstl-Baml-II K-ras  vm2 fragment from pSWlI-1 was sub- 
cloned  into  the  Pstl  site  of  pLF/SV-40/Blueseript  using  a  BamHI- 
1. Abbreviation used in this paper:  TAg,  T  antigen. 
PstI  oligodeoxynucleotide  adapter  (5'-GATCTGCA-3'),  yielding  pLF/ 
K_rasV~12/SV.40/Bluescript.  L_FABP-596 to +21/K_rasW12/SV.40 was  re- 
covered from pLF/K-rasV'l~z/sv-40/Bluescript  as a 2.6-kb XhoI-SacI frag- 
ment  (Fig.  1  D)  and  used  for  pronuclear  injections.  K-rasVmZ/SV-40 
splice-polyadenylation  DNA  was  recovered  from  pLF/K-rasVm2/SV-40/ 
Blueseript as a  2.0-kb  BamHI  fragment.  A  pBR325-based recombinant 
plasmid containing I-FABP  -117s to +2s/SV.40 TAg (34)  was digested with 
BamHI to excise the 2.7-kb coding sequence for SV-40 TAg. The K-rasWl2/ 
SV-40  BamHI  fragment  was  subsequently  ligated  to  BamHI-digested 
I_FABP-t ~Ts to +2S/pBR325 DNA,  yielding pIF/K-rasVal12/SV40/pBR325. 
I.FABP-H7s  to  +2SlK_rasVmelSV.40  splice-polyadenylation  DNA  was 
retrieved as  a  3.2-kb  BspEI-BanI  fragment (Fig.  1 B)  for pronuclear 
injections,  plF/K-rasW12/SV-40/pBR325  was  digested  with  BstEII  and 
BsrFI,  The  2.2-kb  fragment  released  by  these  restriction  enzymes 
(I_FABP-I~ to +2S/K_rasWdt2/SV.40 splice-polyadenylation; Fig. 1 B), was 
used for pronuclear injections. 
I.FABP-H~8  to +2S/pJ3Wt and I-FABP  -Hrs to  +28/pj3Ala143. A  1.2-kb 
EcoRI-PstI fragment of pEPI-FABP (74), containing nucleotides -1178 to 
+28 of rat Fabpi, was subcloned into EeoRI-PstI digested pBluescript KS 
(Stratagene, LaJolla, CA). The Fabpi sequences were then excised using 
Sail  and  PstI.  The  resulting  1.2-kb  Sall-PstI  fragment was  ligated to 
pLF/SV-40/Bluescript (after nucleotides -596 to +21 of rat Fabpl had been 
removed with SalI-PstI). This ligation created plF/SV-40/Bluescript which 
placed the Fabpi promoter sequences upstream of the 0.9-kb fragment con- 
taining SV-40 splice/polyadenylation signals. A partial BamHI digest of the 
recombinant plasmid was performed since a second BamHI site was present 
at the 3' end of the SV-40 sequence. Full-length, linearized DNA was iso- 
lated by agarose gel electrophoresis. A  1.8-kb fragment containing wild- 
type p53  eDNA (I)53  wt) was obtained by digesting pC53-SN3  (5)  with 
BamHI.  p53  wt  DNA  was  then  ligated  to  lineafized  BamHI-digested 
plF/SV-40/Bluescript. Correct orientation of the p53  wt eDNA downstream 
from I-FABP  -117s to +28  and upstream from the SV-40  splice/polyadan- 
ylation  sequences  (Fig.  1  C)  was  confirmed by  diagnostic  restriction 
digests.  I-FABP  -HTs  to  +2S/p53^lavt3 was  made by  subcloning a  1.8-kb 
BamHI  fragment  of pC53-SCX3  (5)  into  plF/SV-40/Bluescript.  Both 
I.FABP-HTs  to  +28/p53Wt and  I-FABP  -HTs  to  +2S/p53Ala143 DNAs  were 
released from vector sequences using HindlII and SpeI to give 4.0-kb frag- 
ments (Fig.  1 C) which were used for pronuclear injections. 
Production of Transgenic Mice 
All FABP/oncogene DNAs were purified by agarose gel electrophoresis fol- 
lowed by glass bead extraction (Geneclean II Kit; Bio 101 Inc., LaJolla, CA) 
and passage through a 0.2-t~m Ultrafree MC Filter Unit (Millipore Corp., 
Bedford, MA). Each purified preparation of DNA was adjusted to a final 
concentration of 2 ng//~L TE buffer (10 mM Tris, 0.2 mM EDTA, pH 7.4). 
Pronuclear injections were performed using zygotes prepared from inbred 
FVB/N animals (Taconic  Farms Inc., Germantown, NY).  Injected eggs 
were transferred to pseudopregnant Swiss Webster females using standard 
techniques (36). 
Live-born animals were screened for the presence of  transgenes using the 
PCR, tail DNA, and the primers described in Fig. 1. Transgene copy num- 
ber was determined by Southern blot hybridization analysis of BamHI- 
digested spleen DNA prepared from Ft or F2 mice. Blots were probed with 
a 32p-labeled, 0.9-kb DNA containing the SV-40 splice/polyadenylation se- 
quences present in every FABP/oncogene construct (see Fig. 1, A-D).  Sig- 
nal intensities produced by the DNAs from each pedigree were compared 
with signal intensities produced by known amounts of purified FABP/onco- 
gene DNA included in each blot. 
Members of FVB/N pedigrees with different FABP/oncogene DNAs were 
mated to produce multi-transgene mice. Tail DNA prepared from the prog- 
eny of these crosses was screened by PCR using primer pairs that were 
specific for each DNA construct and would amplify a different sized frag- 
ment (Fig.  1). This allowed us to use a single PCR reaction to perform a 
complete analysis of an animal's component transgenes. 
Maintenance of Transgenic Mice 
Transgenic mice and their normal litterrnates were maintained in microiso- 
lator cages under a strict light cycle (lights on at 0600 and off at 1800 h). 
Cages were changed in laminar flow hoods. Serologic studies confirmed  that 
all mice used in this study were free ofpathogans including murine hepatitis 
virus.  Each  transgenic pedigree was  maintained by  crosses to  normal 
FVB/N littermates. Animals were given a standard autoclavable chow diet 
(No. 5010; Ralston Purina, St. Louis, MO) ad libitum. Transgenic mice and 
their normal littermates received an intraperitoneal injection of 5'-bromo- 
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EcoRI  I  ~mHI  Bah'iN  pair  Product 
I  ~/~11  A "  C  7g0 bP 
I-FABp'II7S to .281SV40  TAg  I-FASP  .~e to .=J  8V40 T Antigen (2.7 kb) 
i  %  B  +  D  380  bp 
EcoRI  BIIEI lBamHt  Pet I  BamHI 
Ba,=l  II  II/~'1'  ~Ba°'  I'FABp117st°°2elK'rasVaN=  ~  1  A  *  E  740  bp 
I-FABP -184 to *28  iK.rasVa112  I-FABP  .me t* .28  K-ru  ~'m (tUtb)  SV40 *pice/polyA  (0~)kb  /  I  ~  84"F  450bp 
-1178  -184  F  E 
[]  ~  ~  ~coRI 
-  1t7  ...,0. 7 
I-FABp'It7S 1o *28/p53Wt  Hind II [  T--C:VILI143--Ale  Spa |  1  A  +  G  500  bp 
I-FASP  -ms to *a  p53 (1,rob) 
I.FABp.II7S to.2elp53Ala143  I  B  +  G  180  bp 
[~  "-, 
EcoRI  B~mHI  Psi I  BamHI 
i,/P,,,  .l.  f/Ba°' 
L.FABp.sSs to .21 iK.rasV=n2  ~_~ L.FABP  ~l°'=n  Kqqll  vzn=  (Llkb)  [SV40 |plcldpolyA  (O~,~b)~  -~  H 4- F 
,j_l 
F 
470 bp 
Figure L Schematic represen- 
tation of FABP/oncogene con- 
struets used to generate trans- 
genie mice and the PCR assays ' 
used to establish their geno- 
type.  The  following  primers 
were  used to genotype mice 
by PCR.  Sense primers:  (A) 
5'-CC'I"rATTACAC-CAGCK~  - 
TAG-3' (nueleotides  -318  to 
-300  of  rat  Fabpi);  (B) 
5'-A  TCTCTGCTTTCCT A G- 
A~CACACAG-3'  (nucleo- 
tides +  1 to +28 ofrat Fabpi); 
(H)  5'-CAG~'IV,  C,  CCT- 
GGCAGACAG-3' (nucleotides 
-25  to -4  of rat Fabpl). An- 
tisense primers:  (C)  Y-CAT- 
CCTCAGTAAGCACAC-C-3' 
(nucleotides  4790  to  4808 
of the  SV-40 genome);  (D) 
5'-TAAGGAAGAAGCAA- 
ATACCTCAGTTGCATCC- 
CAG-3' (nucleotides  4886 to 4919 of SV-40); (E) 5'-GCCTGTTTTGTGTCTACTGTTCTGGAAGC~-Y  (nucleotides  389 to 360 of exon 
3 of  K-ras); (F) 5'-GGACCATA~CATCTTCAGAGTCC-3'  (nucleotides 336 to 312 of  exon 3 of  K-ras); (G) 5'-ACTGCGC~TCCTCCA- 
TGGCAGTGACCCGGAAGC~AGTCTG-3'  (nucleotides  230 to 191  of exon 2 of p53). 
deoxyuridine (BrdUrd; 120 mg/kg body weigh0 and 5'-flouro-deoxyuridine 
(12 rng/kg)  1.5 h before sacrifice to label cells in S-phase (15). All mice were 
killed by cervical dislocation. 
Analysis of Regional and Cellular Patterns of 
Transgene Expression 
The  gastrointestinal tract  was  removed  immediately after sacrifice and 
divided into eight segments-stomach (ST),  duodenum (DU),  proximal 
jejunum (PJ), distal jejunum (DJ), ileum (IL), cecum (CE), proximal colon 
(PC), and distal colon (DC)-according to a protocol described in Sweetser 
et al. (75).  A 5-ram cross-sectional biopsy of each segment was recovered 
for histologic studies and fixed in Bouin's fluid. The remaining tissue from 
each small intestinal segment was weighed before RNA extraction. Colonic 
segments were not weighed due to marked animal-animal variations in the 
amount of luminal contents. Eight extra-intestinal tissues were also recov- 
ered for RNA isolation. These included brain, heart, lung, liver, spleen, 
pancreas, kidney, and skeletal muscle. Total  cellular RNA was prepared 
from pulverized frozen tissues using the method of  Chomczynski and Sacchi 
(12). The integrity of RNA preparations was assessed by denaturing agarose 
gel electrophoresis (63). 
Tissue RNA was subjected to ribonuclease protection assays (63) to de- 
tect  mRNA  transcripts derived  from transgenes  and  from  endogenous 
mouse genes. SV-40 TAg mRNA was identified using a 178-base riboprobe 
(cRNA) derived from nucleotides 4886 to 5033 of the viral genome. The 
resulting protected sequence is 127 nucleotides long. A 32p-labeled,  199- 
base cRNA yields a  148-base protected fragment when annealed to the 
mRNA transcript of I-FABP  -ltTs to +2S/k.rasV~|2 (N.B. this protected frag- 
ment includes nucleotides 143 to 244 of human K-ras  veu2 mRNA). The 
same cRNA produces a  54-base protected fragment when hybridized to 
mouse  c-K-ras  Gnyl2 mRNA.  Production  of  wild-type  and  mutant  p53 
mRNAs  was monitored using  a  200-nucleotide riboprobe which spans 
exons 5 and 6 of the human p53 gene (5). This cRNA recognizes the prod- 
ucts of the two [-FABP  -117s to +2S/p53 transgenes (Fig.  1 C) as a  150-base 
protected fragment and the mRNA product of the endogenous mouse p53 
gene as an 80-base fragment. Expression of mouse Fabpi was assayed using 
a 32p-labeled  562 base riboprobe. This cRNA generates a 501-nucleotid¢ 
protected fragment when hybridized to nucleotides +121  to  +621  mouse 
I-FABP mRNA. The mRNA products of the wild-type Ape gene and its mu- 
tant Min allele (Ape  Min) were measured using a  242-base cRNA which 
spans nucleotides 2527 to 2649 of Min cDNA (72).  It yields a protected 
fragment of 123 bases when hybridized to Ape  "~in mRNA and a protected 
fragment of 100  bases when hybridized to wild-type Ape mRNA. Poly- 
acrylamide gels containing protected fragments were scanned with a radio- 
nuclide imager (Betngen, Waltham, MA). The intensity of the signal ob- 
served with each sample of tissue RNA was compared to the intensities of 
signals produced from known amounts of purified, in vitro transcribed, 
mRNA standards. 
Bouin's fixed tissue samples were embedded in paraffin. 5-/~m-thick sec- 
tions were prepared and stained with hematoxylin and eosin or subjected 
to single or multilabel immunocytocbemical analyses using protocols de- 
scribed in our previous publications (35,  61).  The antisera used for these 
studies, their sources, final dilutions, and cell lineage specificities were as 
follows: goat anti-BrdUrd (1:1000-1:5000,  references 13, 15; S-phase cells), 
rabbit anti-rat intestinal (I) -FABP (1:1000, reference 15; enterocytes), rab- 
bit anti-rat liver (L) -FABP (1:1000, references 69, 75; enterocytes), rab- 
bits anti-rat alkaline phosphatase (1:5000;  reference 34;  enterocytic lin- 
eage),  rabbit  anti-human  lysozyme  (1:500;  reference 62;  Paneth  cell 
lineage), rabbit anti-serotinin (1:4000;  Incstar Co., Stillwater,  MN;  sub- 
population of the enteroendocrine lineage), and rabbit anti-substance P 
(1:2000;  reference  60,  subpopulation  of the  enteroendocrine lineage). 
Members of the goblet cell lineage were identified using the Periodic Acid 
Schiff (PAS) stain plus members of a panel of lectins with well defined car- 
bohydrate specificities. SV-40 TAg was detected in Bouin's fixed sections 
with a rabbit anti-SV-40 TAg serum (1:2000;  D.  Hanahan, University of 
California, San Francisco) and in acetone-fixed frozen sections with a ham- 
ster antibody (1:1000;  reference 34).  Antigen-antibody complexes were 
visualized either with fluorescent-labeled second antibodies or with gold- 
labeled second antibodies and silver enhancement (35,  61). 
Histopathologic  Analysis of Gut Epithelium 
A histological grading scheme was devised based on the pattern of BrdUrd 
staining observed along the crypt-villus (or crypt-surface epithelial cuff) 
axis and on the degree of dysplasia noted in hematoxylin and eosin stained 
sections: 0,  normal pattern of BrdUrd staining (S-phase cells limited to 
crypts) normal crypt-villus architecture; 1, mild increase in BrdUrd label- 
ing with extension of S-phase cells to the lower third of the villus-normal 
crypt-villus architecture; 2, moderate increase in BrdUrd labeling extend- 
ing to mid-villus; mild dysplasia; 3, marked increase in BrdUrd labeling ex- 
tending to upper third of the villus-moderate to severe dysplasia; 4, ade- 
noma; 5,  adenocarcinoma. 
The proximal and distal halves of the small intestine (PSI and DSI, 
respectively) and the proximal half of the colon (PC) from each animal was 
surveyed by examining multiple cross sections of each segment or sections 
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in a single blinded fashion to minimize bias. 
Analysis of  Mice Carrying a Mutant Allele of the 
Murine Homolog of  APC (Apc  Min) That Is Associated 
with Multiple Intestinal Neoplasms 
C57B1/6 Min/+ animals were re-derived by embryo transfer to assure our- 
selves that they were free of murine hepatitis virus. These animals, as well 
as the progeny of FVB/N X C57Bl/6 Min/+ or C57B1/6 Min/+ X FVB/N 
I.FABP-IITs to +2S/oncogen  e crosses, were identified as having a T"*A tran- 
sition in codon 850 of Apc (72) by PCR analysis of tail DNA. The 23-base 
upstream sense primer spanned nucleotides 2526 to 2549 of the Min allele's 
open reading frame and contained the mutated A residue at its 3' end (5'- 
CGTTCTGAGAAAGACAGAAGTTT_A-Y).  The  antisense  (downstream) 
primer spanned nucleotides 3065 to 3046 of the wild-type Apc sequence 
(5'-GGTGTATCCAGTTCTCCATC-39.  This primer pair only amplified the 
mutant Min allele, producing a 539-bp product. 
Animals  carrying  Min  were  injected  with  BrdUrd  90  min  before 
sacrifice. After animals were killed by cervical dislocation, their gastroin- 
testinal tract was subdivided as described above. Each segment was then 
opened along  its  longitudinal  axis  and  immediately  fixed overnight in 
Bouin's solution. The number of intestinal neoplasms/segment was scored 
using a dissecting microscope. Segments were then rolled up and embedded 
in paraffin. 5-10-~m sections were prepared from these Swiss rolls and 
stained with hematoxylin and eosin or surveyed with our panel of anti- 
bodies. 
Statistical Analysis 
Statistical analysis of animal weights were performed by ANOVA using a 
P value of <0.05 as the cut-off for significance. Histopathologic scores were 
compared between single and multi-transgenic animals and their normal lit- 
termates using Fishers Exact test with P < 0.05 considered to be statistically 
significant. SAS, version 6 (65)  was used for these computations. 
Results and Discussion 
A large number of studies indicate that human colonic neo- 
plasms arise from a multistep process. Initiation is thought 
to occur by somatic mutation of one or a small number of 
cells located in a  single crypt (23).  These mutations may 
affect the adenomatous polyposis coli (APC) gene, which is 
thought to function as a tumor suppressor (32,43) and/or the 
closely linked mutated in colorectal cancer gene (MCC) 
(44). The proposed consequence of these, or other, somatic 
mutations is to alter the proliferative potential of  the initiated 
cell, leading to the development of small monoclonal ade- 
nomas. Subsequent progression appears to occur through a 
combination of mutational activation of proto-oncogenes 
and inactivation of  tumor suppressor genes. These mutations 
frequently affect c-K-ras (7, 25,  80),  the DCC (deleted in 
colorectal cancer) locus (24),  and the p53 gene (4). Defects 
in the accuracy of DNA replication, controlled by a locus 
on human chromosome 2 (FCC), also appear to be associ- 
ated with the development of hereditary nonpolyposis colo- 
rectal cancers and, possibly, sporadic colonic neoplasms (1, 
57, 77). 
We examined the effects of some of these gene products on 
gut epithelial differentiation/proliferation programs by ex- 
pressing them singly and in combination in transgenic mice. 
Pedigrees of mice were initially established carrying nucleo- 
tides  -1178  to  +28  of the rat intestinal fatty acid bind- 
ing protein gene (Fabpi; reference 74) linked to open read- 
ing frames encoding SV-40 TAg,  K-ras  v~12, and p53 Am43. 
i_FABP-U7s to +2s was selected because functional mapping 
studies conducted in transgenic mice had shown that it con- 
tains cis-acting elements which restrict expression of foreign 
gene products to nonproliferating members of the entero- 
cytic lineage; i.e., reporter production is initiated just as en- 
terocytes exit duodenal, jejunal, ileal and proximal colonic 
crypts. Expression is sustained as these cells complete their 
migration to the apical extrusion zone of villi or surface epi- 
thelial cuffs (15). Highest steady-state levels of reporter are 
encountered in the distal jejunal enterocytes with progres- 
sive declines occurring as one moves to the duodenum and 
to the proximal half of the colon  (15). I-FABP  -1178  to +28/ 
reporter transgenes are activated on embryonic day 15/16, 
coincident with cytodifferentiation  of the pseudostratified fe- 
tal gut epithelium to a monolayer overlying nascent villi. Ex- 
pression is maintained along the duodenal-colonic axis for 
at least the first 12-14 mo of life. I-FABP  -llTs  to +2S/oncogen  e 
transgenics were generated using inbred FVB/N zygotes (76) 
so as not to vary the genetic background when multiple on- 
cogenes were introduced into a  single mouse by pedigree 
crosses. We hoped that these initial studies would allow us 
to  (a)  define the proliferative potential of differentiating/ 
differentiated villus-associated enterocytes,  (b)  determine 
whether enterocytes were capable of undergoing dedifferen- 
tiation in response to production of these gene products, and 
(c) ascertain if changes in proliferation/differentiation  pro- 
grams would progress; e.g., through clonal expansion of ini- 
tiated cells and acquisition of subsequent somatic mutations. 
Analysis of  Mice with Single I-FAB  P n~ t° +  2s/ 
Reporter Transgenes 
i.FABP-ms  to  +WSV-40 TAg. Two  pedigrees  of FVB/N 
I-FABP  -t17s  '° +2s/sv-40 TAg mice with  10-20-fold differ- 
ences in the levels of SV-40 expression were studied (Table 
I). The pattern of I-FABP  -lan ,o +2s/sv_40 TAg expression in 
10-12-wk-old  transgenic mice belonging to each pedigree 
mimicked that of the intact, endogenous mouse Fabpi gene 
(Fig. 2 A). Analysis of 1-12-mo-old  F1-F3 mice from each 
line revealed that the concentration of SV-40 TAg mRNA in 
small intestinal and colonic RNA remained constant during 
the first year of life and that the transgene was not expressed 
in liver, kidney, pancreas, spleen, heart, lung, skeletal mus- 
cle,  and brain (limits of detection  =  0.01 pg SV-40 TAg 
mRNA//~g total cellular RNA). 
Immunocytochemical surveys of mice belonging to the 
high expressing line 103 and the low expressing line 48 dis- 
closed that SV-40 TAg is first detectable in enterocytes as 
they exit crypts. Transgene expression is sustained as these 
cells complete their upward migration to the apical extrusion 
zone of villi and to surface epithelial cuffs (e.g., Fig. 3, A 
and C). The distribution of SV-40 TAg along the crypt-villus 
axis is similar in animals belonging to lines 48 or 103. Only 
the intensity of nuclear staining is different, paralleling the 
differences in mRNA concentration (data not shown). 
The  effect of SV-40 TAg  on cellular proliferation and 
differentiation was defined from the duodenum to the colon 
by (a) noting the distribution of cells in S-phase along the 
crypt-villus or crypt-surface epithelial cuff axis of mice that 
had been treated with BrdUrd  1.5  h  before sacrifice;  (b) 
surveying the number of villus-associated cells in M-phase 
in  hematoxylin and eosin  stained  sections;  (c)  assessing 
whether there were any distortions of crypt-villus architec- 
ture or changes in cellular morphology; and (d) examining 
the expression of several  lineage-specific gene products. 
Line 103 mice between 8 and 210 d of age have numerous 
The JouFna~ of Cell Biology,  Volume 123, 1993  880 Table L  Summary  of Pedigrees  of FVB/N Transgenic Mice 
No. of  No. of  No. of  Expressing 
live-born  transgenic  expressing  pedigree  Transgene 
Transgene  animals  founders  lines*  designation  copy no. 
I_FABP-ms to +2s/sv_40 TAg 
I_FABP-HTs to +2S/K.rasVa112 
I_FABP-I  m to +2S/p53  w' 
I_FABP-H7a to *28/p53A|e143 
I_FABP--lu ~o +2S/K_rasV~12 
L_FABP-S~ ~ +21/K_rasVm2 
103  2  2  48  5 
103  121 
96  12  5  24  4 
33  14 
57  ND 
73  53 
81  ND 
73  3  0  -  - 
41  5  2  4  1 
14  1 
89  3  1  65  ND 
61  7  2  39  1 
44  1 
* Defined by the presence of detectable  levels of reporter  mRNA in samples of jejunal  RNA using a sensitive ribonuclease protection  assay. 
enterocytes in S-phase distributed from the base to the apex 
of duodenal, jejunal, and ileal villi (Fig. 3 A). M-phase cells 
are also present throughout the villus but are less numerous 
than  S-phase  cells  (Fig.  3  B).  Marked  alterations  in 
crypt-villus architecture are apparent, typically manifested 
by bizarre, branched villi (Fig. 3 E). These changes result 
in an average histopathologic grade of 2 in both the proximal 
and distal halves of the small intestine (Table 11). This value 
is significantly different (P <  0.001) from values obtained 
from normal littermates. Modest proliferative abnormalities 
are also evident in the proximal half of the colon (average 
histopathologic grade  =  1.3;  Fig.  3,  C,  D,  and P).  The 
proliferative changes  observed along the crypt-villus and 
duodenal-colonic axes of G0103-derived mice are not as- 
sociated with any detectable changes in the pattern of ac- 
cumulation of L-FABE I-FABP (Fig. 3 F), or alkaline phos- 
phatase in enterocytes (data not shown). The differentiation 
programs of the three other principal gut epithelial cell line- 
ages appears unperturbed, at least as operationally defined 
by our panel of antibodies and lectins and by light micro- 
scopic studies of cellular morphology (data not shown). 
Surveys of hematoxylin and eosin stained sections pre- 
pared from Swiss rolls of small and large intestine failed to 
reveal any adenomas  in 7-9-too-old G0103-derived mice. 
However, these animals often die of intestinal obstruction by 
9 mo of age. This is due to large submucosal tumors in the 
proximal colon. These lesions are not apparent until 6-7 mo 
of age and are composed of SV-40 TAg-positive cells (Fig. 
3  G).  Transmission EM  revealed nests and aggregates of 
neoplastic cells surrounded by a basal lamina (Fig.  3 H). 
The  individual  cells  contain variable numbers  of round, 
electron-dense, neurosecretory granules. The granules have 
a diameter of 100-200 um and possess no obvious peripheral 
halo.  These ultrastructural features are characteristic of a 
neuroendocrine cell neoplasm. There was no prior evidence 
that Fabpi or I-FABP  -11vs ~ +~S/reporter transgenes are ex- 
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Figure 2.  Regional patterns 
of expression  of transgenes 
along the cephalocaudal axis 
of FVB/N mice.  The steady 
state  concentrations  of  re- 
porter  mRNAs were  deter- 
mined in 1O-12-wk-old  trans- 
genie mice using ribonuclease 
protection  assays (see  Mate- 
rials and Methods). The num- 
ber  of mice  surveyed  from 
each pedigree was as follows: 
(A) line 103, n = 5 mice; line 
48, n  =  3; (B) line 24, n  =  3; 
line 33, n = 3, line 73, n = 3; 
(C) G04 was sterile; line 14, 
n =  3. ST, stomach; DU, du- 
odenum;  PJ,  proximal jeju- 
num; D  J, distal jejunum; IL, 
ileum; CE, cecum; PC, prox- 
imal colon; DC, distal colon 
(defined  according  to 
Sweetser  et  al.  [75]).  An 
asterisk  indicates  that  the 
mRNA  species  was  not  de- 
tectable  in  RNA  prepared 
from this segment. 
Kim et al.  Transgenic Mouse Models of lntestinal Neoplasia  881 Figure 3. Analysis of the effects of SV-40 TAg and K-ras  wl2 on the proliferation and differentiation programs of villus-associated  entero- 
cytes. SV-40 TAg and BrdUrd were detected in sections of jejunum or proximal colon with rabbit anti-SV-40 TAg and goat anti-BrdUrd 
sera. Antigen-antibody  complexes were visualized using fluorescein-, also Cy3 Texas red-, or gold-labeled  donkey anti-rabbit  or anti-goat 
sera. (,4) A section of jejunum from a 10-wk-old I-FABP-It78t°+Ea/SV-40  TAg transgenic mouse belonging to the high expressing line 103 
was incubated with antibodies directed against both BrdUrd and SV-40 TAg. BrdUrd-labeled nuclei in proliferating, crypt-associated  cells 
do not contain detectable levels of SV-40 TAg and therefore appear red in this dual exposure photomicrograph. Cells containing both SV-40 
TAg and BrdUrd are evident in the villus and appear yellow-orange. Nonproliferating, villus-associated enterocytes that contain SV-40 
TAg appear green.(B) A hematoxylin- and eosin-stained section prepared from the jejunum of a 10-wk-old Go 103-derived I-FABP  -lm to +28/ 
SV-40 TAg transgenic mouse reveals scattered villus-associated  enterocytes in M-phase (arrows). (C and D) A section of proximal colon 
from an SV-40 TAg transgenic mouse belonging to line 103 was incubated with antibodies directed against BrdUrd (visualized with Texas 
red-labeled donkey anti-rabbit sera) and SV-40 TAg (visualized with gold-labeled donkey anti-rabbit serum followed by silver staining; 
photographed with reflected light polarization microscopy). S-phase cells are apparent in the upper third of these colonic crypts and their 
associated surface epithelial cuffs (C). SV-40 TAg production is evident in proliferating (yellow-orange) and nonproliferating (aqua) cells 
(D). (E) This hematoxylin- and eosin-stained section of  jejunum illustrates  the many dysplastic, branched villi encountered in 10-12-wk-old 
Go 103-derived SV-40 TAg mice. (F) Despite these proliferative changes, the pattern of endogenous Fabpi expression remains unchanged 
in members of the high expressing SV-40 TAg pedigree. Dual labeling with rabbit anti-I-FABP serum (detected with fluorescein-labeled 
donkey anti-rabbit serum) and goat anti-BrdUrd serum discloses I-FABP (green) in villus-associated  enterocytes in S-phase (yellow-orange 
nuclei). (G) Go 103-derived I-FABP  -H78 to +28/SV_40 TAg mice develop large submucosal neoplasms in their proximal colon between 6 
and 7 mo of age. The tumors consist of cells with high nuclear to cytoplasmic ratios, frequent mitotic figures, and a  scant interlacing 
The Journal of Cell Biology,  Volume 123, 1993  882 Table II.  Histopathologic  Analysis of FVB/N Mice Carrying Single I-FABP  -n7s to +28/Reporte  r  Transgenes 
Histologic grade* 
Reporter  Pedigree  n  Age  PSI  DSI  PC 
-  Normal FVB/N  1  6 wk  0  0  0 
3  10-12  wk  0  0.3  +  0.5  0.3  +  0.5 
2  9 mo  0  0  0 
SV-40 TAg  48  1  6 wkt  1  1  0 
5  10-12  wk*  0.6  5- 0.5  0.6  5- 0.5  0.2  5- 0.4 
1  9 mot  1  2  0 
103  3  10-12 wk  1.7 +  0.5  2.3  +  0.5  1.3  5- 0.5 
3  7 mo  2  +  0  2.3  5- 0.5  1.3  5-  1.2 
K-ras  vail2  24  1  6 wk  1  1  0 
2  10-12  wk  0  0.5  5- 0.5  0.5  5- 0.5 
1  9  mo  0  0  0 
33  2  10-12  wk  0  0.5  5- 0.5  0.5  5- 0.5 
1  9  mo  0  0  0 
73  3  10-12  wk  0  0  5- 0  0  5- 0 
1  9  mo  0  0  0 
p53  A1"143  4  1  19 wk  0  1  0 
14  4  10-12  wk  0.25  5- 0.4  0.25  5- 0.4  0.25  5- 0.4 
1  28 wk  0  0  1 
* The histologic  grading system used to score each segment is described in Materials  and Methods. 
t Analysis  of six nontransgenic littermates.  6;  10-12, and 36 wk of age revealed scores of zero in each of these segments. 
n, number of animals scored; PSI, proximal half of small intestine; DSI. distal half of small intestine;  PC, proximal  colon. 
pressed in small intestinal or colonic enteroendocrine cell 
populations (15).  The late appearance of proximal colonic 
endocrine neoplasms  in  this pedigree suggests that  SV-40 
TAg may only be produced in a small subset of enteroendo- 
crine cells. "Initiated; SV-40 TAg-positive colonic enteroen- 
docrine cells may be more likely to progress to dysplasia and 
neoplasia since their turnover time (23  d;  reference 79) is 
considerably slower than the turnover times of small intesti- 
nal enteroendocrine cells (4 d; reference 10) (e.g., transgenic 
mice carrying nucleotides -2100 to +58 of the rat glucagon 
gene linked to SV-40 TAg exhibit no detectable abnormali- 
ties in their small intestinal endocrine cell populations but 
develop focal areas of colonic enteroendocrine hyperplasia 
that  progress  to  invasive  plurihormonal  endocrine  neo- 
plasms by the end of the fourth postnatal week) (48). 
Mice from the low-expressing line 48  contain far fewer 
villus-associated enterocytes in  S-phase than  age-matched 
animals from  line  103  and have essentially no  changes  in 
crypt-villus architecture (Table II). Their colonic epithelium 
appears normal.  They have no detectable abnormalities in 
the  differentiation  program  of  their  villus-  and  surface- 
epithelial cuff associated neuroenterocytes (Fig. 4  and data 
not shown) nor do they have any neoplasms, including the 
endocrine tumors  seen  in the proximal colon of line  103 
mice. 
i.FABP-llrs ,o +ZS/K.rasV~:" 12 transgenic founders carry- 
ing  I-FABP  -Itys  to  +28/K_rasW,12 were  identified  among  96 
live-born mice screened (Table I). Ribonuclease protection 
analysis of jejunal RNA prepared from FI animals revealed 
that five pedigrees expressed the transgene (Table I). Levels 
of K-ras  v~2 mRNA in  10-12-wk-old animals from each of 
the three lines we studied were markedly lower than SV-40 
TAg  mRNA  (Fig.  2,  A  and  B).  The  regional pattern  of 
I_FABP-1178  to  +28/K_rasW~2 expression  along  the  duode- 
nal-colonic axis was generally similar to that of Fabpi (Fig. 
2 B). K-ras  v~2 mRNA was not detectable in RNA prepared 
from the stomach, colon, or 8 extraintestinal tissues in any 
of the lines studied (Fig. 2  B  and data not shown). 
K-ras  w'~2 expression in postmitotic villus-associated en- 
terocytes produces no significant phenotypic abnormalities. 
stroma. Enterocytes in the overlying colonic epithelium (open arrows) as well as the neoplasms poorly differentiated cells (closed arrows) 
contain SV-40 TAg (G). (H) EM examination of glutaraldehyde-fixed tumor shows nests and groups of neoplastic cells surrounded by 
a basal lamina. The cells contain numerous, round, electron-dense, neurosecretory granules at their periphery. These ultrastructural fea- 
tures  are characteristic of a  neuroendocrine cell neoplasm.  (I)  In contrast to  the pedigrees carrying I-FABP  "n78 to  +28/SV..40  TAg, 
I-FABP  -nTst° +28/K-ras  v'~12 transgenic mice have no detectable abnormalities in the proliferation or differentiation programs of their entero- 
cytes. This is illustrated by the normal pattern of BrdUrd and I-FABP staining along the crypt-villus axis of the jejunum in a  10-wk-old 
animal. (J-N) When I-FABP  -ll7st° +28/K-ras  vail2 mice are crossed to I-FABP  -n788t° +2s/SV-40 TAg animals, the resulting bi-transgenic prog- 
eny exhibit proliferative and cytologic abnormalities in their villus epithelium. Comparison of high magnification photomicrographs of 
hematoxylin and eosin sections of jejunum prepared from a  10-wk-old bi-transgenic mouse (K) and a comparably aged normal FVB/N 
animal (L) underscores the marked increases in mitotic activity, in nuclear pleomorphism, and in nuclear-cytoplasmic ratios. (M and N) 
Despite the marked distortions in crypt-villus architecture (M) and the proliferative changes which occur in SV-40 TAg X K-ras  v~12 bi- 
transgenic mice, Fabpi expression appears to be sustained in their villus-associated  enterocytes (N). Go 103-SV-40 TAg X Go 73 K-ras  wz2 
mice have a hyperplastic and dysplastic proximal colonic epithelium (O) compared to their SV-40 TAg parent (P). Bars: (A-C, L  and 
O) 25 ~m; (E, F, and M) 50/~m;  (H)  1 /zm; (K) 10 #m. 
Kim et al. Transgenic Mouse Models of Intestinal Neoplusia  883 tn 
>  1.0 
._1 
< 
z  0.8 
rr 
E 
a.  0.6 
0.4 
® 
0.0 
Figure  4. 
J3 
Effect  of I-FABP  -n7s to  +Woncogene transgenes  on 
steady-state levels of I-FABP mRNA in the small intestine of  young 
adult FVB/N mice. A ribonuclease protection assay was used to de- 
termine the concentration of I-FABP mRNA in total cellular RNA 
prepared from the distal jejunum and ileum of transgenic mice. 
I-FABP mRNA levels are expressed relative to levels observed in 
the distal jejunum of nontransgenic littermates. Values shown for 
I_FABp-u7s to  +WK.rasV~lZ transgenics  were  determined  from 
animals belonging to lines 24, 33, and 73 (n =  ten 10-12 wk-old 
mice).  Three 10-12-wk-old I-FABP  -nTs to +2S/p53Al~143 mice from 
pedigree 14 were surveyed. At least three 10-12-wk-old mice were 
examined from each of two SV-40 TAg-producing pedigrees and 
from each of the two types of SV-40 TAg X K-ras  v~n crosses. 
BrdUrd-positive cells are not present in small intestinal villi 
(Fig.  3  I).  There are  no villus-associated enterocytes in 
M-phase  and there  are  no  distortions  in  crypt-villus ar- 
chitecture (Table II).  Extensive immunocytochemical sur- 
veys in 1-9-mo-old mice from each of  the three pedigrees did 
not reveal any perturbations in the differentiation programs 
of any of the four gut epithelial cell lineages (Figs. 3 I and 
4; and data not shown). No tumors were seen in 9-mo-old 
mice  even  though  I-FABP  -H7s  to  +2S/K.rasV..~ is  still  ex- 
pressed at levels comparable with that encountered at 1-3 mo 
of age. 
I-FABP  -ms  ~ +ZS/p53  A~'m and  I-FABP  -ms  to  +Wp53Wt. 
p53 is thought to play an important role in regulating cellular 
proliferation, differentiation, and survival: (a) effects on the 
cell cycle have been demonstrated in normal and transformed 
cells (5, 6, 18, 38, 45, 49, 52, 68, 71); (b) it can regulate the 
activities of a variety of promoters, including those that may 
be needed for ongoing cell proliferation (21, 22, 27, 28, 42); 
and (c) p53 may function as a "guardian" of the genome by 
affecting DNA repair in response to injury (38,  45).  p53 
mRNA  is  distributed  along  the  length  of the  duodenal- 
colonic axis of young adult FVB/N mice. Highest steady- 
state concentrations occur in the proximal and distal jejunum 
(Fig.  2  C).  We were unable to detect any p53  along the 
crypt-villus or crypt-surface epithelial cuff axis  of adult 
FVB/N mice using commercially available antibodies. In ad- 
dition, we know of no report describing the pattern of ac- 
cumulation of this protein or its mRNA along this axis in 
adult mice. (In situ hybridization studies of E18.5 mouse in- 
testine have shown that steady-state I)53 mRNA levels are 
higher  in  cells  located  in  the  intervillus epithelium  [the 
precursor to  crypts]  than  in  cells  overlying nascent villi 
[661 .) 
To examine the role of p53 in regulating the proliferation 
potential and differentiation program of villus-associated en- 
terocytes, we generated mice with transgenes encoding ei- 
ther wild-type human p53  (p53  "~) or a  dominant negative 
mutant human protein (p53~,~43). 5 out of 41 live born mice 
surveyed contained I-FABP  -nTs ~ +28/p53A~,143 (Table I). G04 
was sterile and was sacrificed at 19 wk of age. Expression 
of the transgene was seen in the expected gut-specific pattern 
with highest levels in the proximal jejunum (Fig. 2  C).  A 
pedigree was established from G014. Its F~ progeny also ex- 
pressed the transgene along the length of the duodenal-ileal 
axis with highest levels in the proximal jejunum (Fig. 2 C). 
Ribonuclease protection assays indicated that the molar ratio 
of human p53  A~.~43 mRNA to mouse p53  w' mRNA was 2:1 
in the proximal small intestine of members of this pedigree 
(Fig. 2 C). We could not identify any abnormalities in gut 
epithelial proliferation or differentiation programs in these 
mice (Table II and data not shown).  Founder Go4 had no 
apparent phenotypic abnormalities affecting enterocytes or 
any of  the other intestinal epithelial cell lineages even though 
the steady state level of mutant p53 mRNA was three fold 
higher than mouse p53  w, mRNA  in duodenum and prox- 
imal jejunum. 
Three transgenic  founders with  I-FABP  -lm  ~  +Wp53  w, 
were identified (Table I). Two passed the transgene to their 
progeny. None of these mice had detectable levels of wild- 
type human p53 mRNA in intestinal or extraintestinal tissues 
when surveyed at 10-12 wk of age (limits of detection ,,o0.01 
pg p53  wt mRNA/#g total cellular RNA).  Male Go  5~ failed 
to pass the transgene to 20 F~ progeny and did not have de- 
tectable p53  w' mRNA  in either small intestine,  colon, or 
any of  the eight extraintestinal tissues included in our survey. 
Our inability to identify lines of  mice that produce detectable 
levels of human p53  w, mRNA may be because p53  w~ over- 
expression in the gut causes lethality or it may simply reflect 
the effect of sequences flanking the site of insertion of the 
transgene (see reference  46 for a discussion of  difficulties en- 
countered in expressing certain p53 variants in transgenic 
mice). 
Analysis of Mice That Express Two or More 
Oncoproteins in Villus-associated Enterocytes 
Reveals That SV-40 TAg and K-ras  va12 Cooperate to 
Affect Proliferation~Differentiation 
SV-40  TAg  binds  to  and  inactivates  p53  as  well  as  the 
retinoblastoma susceptibility gene product (pRB), a tumor 
suppressor that regulates progression through the cell cycle 
(16, 19,  29).  Members of FVB/N I-FABP  -lm to +2s/SV_40 
TAg pedigrees that express high and low levels of the re- 
porter were crossed to FVB/N mice that produced K-ras  v'n 
and/or p53  ^~,143 so that we could determine whether entero- 
cytes are responsive to these oncoproteins during their resi- 
dence on the villus. Ribonuclease protection assays of  jejunal 
and ileal RNAs  established that (a) the concentrations of 
SV-40 TAg, K-ras  v''n, and p53  ^1"~43 mRNA in mice carrying 
two or three different transgenes were comparable to levels 
observed in their single or bi-transgenic parents and (b) these 
mRNAs  did not undergo any appreciable time-dependent 
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Histologic Grade* 
Transgenic crosses  n  Age  PSI  DSI  PC 
SV-40 TAg (48) ×  K-ras  v~: (73) 
SV-40 TAg (48) x  K-ras  v~'2 (33) 
SV-40 TAg (48) x  K-ras  w~ (24)¢ 
SV-40 TAg (103) x  K-ras  v~: (73) 
SV-40 TAg (103)  x  K-ras  v~'2 (24) 
SV-40 TAg (48) x  p53  ~'143 (14) 
SV-40 TAg (103)  X  p53  ^~43 (14) 
K-ras  v~12 (73) x  p53  A~,143 (14) 
SV-40 TAg (103) ×  K-ras  v~2 (73) 
X  p53  ^1"143 (14) 
1  10 wk  1  2  1 
2  11 wk  1.5  + 0.5  1.5  +  0.5  1.5  +  0.5 
3  9 mo  2 ±  0  1.7 ±  0.5  0.5  +  0.5 
2  11.5 wk  0.5  +  0.5  0.5  ±  0.5  0.5  ±  0.5 
1  6  wk  2  2  ND 
2  10 wk  1.5  ±  0.5  2.5  ±  0.5  2 +  1 
5  7 mo  2.6  ±  0.5  3 +  0  2.2  ±  0.4 
1  12 wk  2  3  2 
2  12wk  2 ±  0  1 ±0  0.5  +0.5 
1  7  wk  1  1  1 
2  10 wk  1.5  +  0.5  2.5  ±  0.5  1.5  ±  0.5 
2  10-12 wk  0 +  0  1 ± 0  0.5  ±  0.5 
1  3  wk  1  2  2 
1  6  wk  2  2  1 
2  10wk  2 ±0  3 ±  0  2 ±  0 
Pedigree  numbers are indicated in parentheses. 
* See Materials  and Methods for a description  of the grading system used to score each segment. 
The  importance  of SV-40 TAg and  K-ras  v~2 mRNA levels in determining  these phenotypic  changes  is illustrated  from the  results  obtained  after  crossing 
members of the low expressing line of SV-40 TAg mice to the K-ras  v~2 pedigree with the lowest steady state level of reporter mRNA (line 24;  see Fig. 2 B). 
The resulting bi-transgenic progeny have the same phenotype as their  G048-derived SV-40 TAg parents (see Table II). 
Abbreviations are defined in Table II. 
changes in their steady-state levels over a  6-40-wk period 
(data not shown). 
As noted above, mice from the low expressing SV-40 TAg 
line have minimal phenotypic abnormalities in their entero- 
cytic population. However, when they are crossed to G033- 
or G073-derived K-ras  w'2 animals,  histopathologic  scores 
in  the  proximal  small  intestine  of their  bi-transgenic off- 
spring increase significantly when compared to age matched 
littermates carrying either I-FABP/SV-40 TAg or I-FABP/ 
K-ras  v~2 alone (P<0.05,  respectively; see Table II/). These 
changes are evident at the earliest time points surveyed (4-6 
wk) and are sustained throughout the next 6-9 mo of life. 
However, histopathologic scores in the proximal colon of the 
bi-transgenic mice are not significantly different from either 
single transgene-containing parents or age matched normal 
FVB/N mice-likely reflecting the absence of detectable lev- 
els of both SV-40 TAg and K-ras  w'2 mRNAs in this portion 
of the gut (see Fig.  2, A and B). 
Bi-transgenic animals obtained from crossing members of 
the high expressing SV-40 TAg line (line 103) to either of the 
high expressing K-ras  w'~2 lines (pedigrees 33 or 73) exhibit 
marked proliferative and dysplastic changes in their small in- 
testinal and colonic epithelium. S- and M-phase cells are evi- 
dent along the length of the villus (Fig. 3, J and K). The nu- 
clear-cytoplasmic ratio in proliferating and nonproliferating 
enterocytes  is  increased  and  cells  with  nuclear  hyper- 
chromatism and atypia are evident (Fig.  3, compare K and 
L). The normal architecture of the crypt-villus axis is greatly 
perturbed.  Numerous  branched  villi  are  present  as  are 
anaplastic polyploid structures  (Fig.  3,  M  and N).  These 
hyperplastic  changes  are  associated  with  significant  in- 
creases in the relative weight of the small intestine (Fig. 5). 
G0103  SV-40 TAg X  K-ras  v~2 mice also have significantly 
different (P < 0.001) histopathologic scores in their proximal 
colon compared to normal, age-matched FVB/N mice (Table 
III). S- and M-phase cells are present in the upper portions 
of colonic crypts and their associated surface epithelial cuffs. 
There are pronounced increases in the cellularity of the sur- 
face epithelial  cuff and  alterations  in  the  nuclear-to-cyto- 
plasmic ratio of enterocytes (Fig. 3, compare O and P). Like 
the proliferative and morphologic changes observed in the 
small intestine, the colonic abnormalities are apparent at the 
earliest time point sampled (postnatal weeks 4-6) and do not 
progress  during  the  next  9  mo  of life.  Co-expression  of 
K-ras  v~2 and SV-40 TAg does not affect the time of appear- 
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Figure 5.  Effect of I-FABP  -"7s to +28/oncogen  e transgenes  on the 
relative  weight  of small  intestine  in  adult  FVB/N  mice.  See 
Materials  and Methods for further details. 
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tumors (data not shown). 
These findings suggest that villus-associated enterocytes 
can support cooperative interactions between oncoproteins 
(37)  during their rapid transit along the crypt-villus axis. 
Since Go  103  SV-40 TAg X  G073 K-ras  v'12 bi-transgenic 
mice demonstrate the most dramatic changes in proliferation 
and  tissue  architecture  when  compared  to  their  single 
transgene-containing parents,  they  were  mated  to  G014- 
derived-p53 Al't43 animals to determine whether the domi- 
nant negative p53  mutant produced progression of these 
abnormalities. We could not detect any differences in prolif- 
erative activity in the small intestinal or colonic epithelium 
of these tri-transgenic offspring and their bi-transgenic par- 
ents at 10 wk of age, even though the steady state levels of 
SV-40 TAg and K-ras  v't2 mRNAs were comparable in all 
mice (Table III and data not shown). Immunocytochemical 
surveys of the duodenal-colonic axis ofbi-transgenic and tri- 
transgenic mice failed to disclose any changes in the differen- 
tiation programs of Paneth cell, goblet cell, or enteroendo- 
crine cell lineages (data not shown).  Despite the marked 
changes in morphology of proliferating and nonproliferating 
duodenal, jejunal, and ileal enterocytes, they contain readily 
detectable levels of I-FABP, L-FABP, and alkaline phospha- 
tase.  Moreover,  the fact that these ceils  are  SV-40 TAg- 
positive provides functional evidence that they produce a 
constellation of transcription factors necessary to support 
expression of I-FABP  -H78 to +2s (and Fabpi;  see Fig. 4). Bl- 
and tri-transgenic mice grow at the same rate as normal 
FVB/N mice and subsequently maintain body weights from 
3-9 mo of age that are not significantly  different from normal 
nontransgenic or single transgene-containing animals (data 
not shown).  This finding provides further support for the 
conclusion that functional maturation of enterocytes is not 
disrupted by production of these oncoproteins. Finally, none 
of the bi-transgenic or tri-transgenic mice examined devel- 
oped intestinal adenomas or adenocarcinomas over a 6-9- 
mo period. 
Two control experiments were performed to examine the 
mechanisms that may produce the phenotypic changes ob- 
served  in  villus-associated enterocytes of SV-40 TAg  X 
K-ras  v'L2 rrfice. First, G048 SV-40 TAg mice were crossed 
to p53 ~a~t43 animals. Addition of the mutant p53 produced 
only minimal differences in the phenotype induced by SV-40 
TAg: histopathologic scores in the proximal small intestine 
of 10-wk-old  bi-transgenic mice were only slightly higher 
than in 10-wk-old G048 SV-40 TAg animals (Table 111; P  = 
0.05)  while no differences in histopathologic scores were 
noted in their distal small intestine or in their proximal colon 
(Table  1II).  Second,  p53 ~a't43 mice were crossed to (3073 
K-ras  v'q2 animals. Unlike the cooperative effects observed 
between ras and mutant p53 in other epithelial cell lineages 
(e.g., prostate) (50), villus enterocytes that coexpress mu- 
tant p53  ~.t43 and K-ras  v't2  without SV-40 TAg  show  no 
significant phenotypic abnormalities when compared with 
enterocytes in comparably aged, normal FVB/N mice (Table 
III and data not shown). It is possible that the dysplastic 
changes in villus-associated enterocytes produced by addi- 
tion of K-ras  wz2 to SV-40 TAg-positive enterocytes could 
be due to their reduced functional pools of mouse p53. Such 
reductions could allow K-ras  v'n to produce "unopposed" 
dedifferentiation  of  proliferating enterocytes. This concept is 
supported by the observation that p53  *aa143 is necessary for 
maintenance of the phenotype of ras-transformed rat embryo 
fibroblasts (82).  If this hypothesis is true, p53~,~43's failure 
to cause progression of  the dysplasia observed in SV-40 TAg/ 
K-ras  v~2 positive enterocytes may be due to the fact that it 
cannot produce further reductions in functional mouse p53 
pools other than what is already achieved by SV-40 TAg (see 
reference 54). Other possibilities include differences in the 
distributions of wild-type mouse and mutant human p53 
along the crypt-villus axis and/or the inability of the mutant 
human protein to produce a dominant negative effect via in- 
teraction with nascent mouse p53 synthesized in enterocytes 
[53]).  The importance of SV-40 TAg-mediated inactivation 
of mouse p53  w' in allowing K-ras  w~2 to exert its effect on 
enterocytes can be tested in at least two ways. SV-40 TAg de- 
letion mutants which lack the ability to bind p53 and/or Rb 
(8,  70) could be expressed in this cell lineage alone, and 
in combination with K-ras  v''2 and/or p53 ^~'~43. I-FABP/K- 
ras  w'12 mice could also be crossed to mice that are homozy- 
gous for p53  null mutations (20). 
Is Gut Neoplasia Initiated in the Crypt Stem Cell or 
One of Its Immediate Descendants ? 
Cellular  differentiation is  generally  viewed  as  a  loss  of 
proliferation potential.  Our  analysis of mice with one or 
more I-FABP  -lm to +ZS/oncogen  e  transgenes indicates that 
differentiated, villus-associated enterocytes are capable of 
re-entering the cell cycle and undergoing dedifferentiation. 
The lack of progression of the dysplastic changes noted in 
SV-40 TAg X K-ras  v'12 bi-transgenic animals, or in SV-40 
TAg  X  K-ras  v'12 X  p53  ^1"~43 tri-transgenic  mice  suggests 
that the products of  these transgenes are not sufficient to sup- 
port functional anchorage of villus-associated enterocytes 
and that these cells are unable to acquire additional somatic 
mutations required for progression,  even over a  9-12-mo 
period.  The  inability  of  these  cells  to  undergo  further 
progression emphasizes (a) the remarkable protective effect 
produced by a  continuously and rapidly renewing epithe- 
lium; (b) the need to identify gene products that may affect 
cell migration rates along the crypt-villus axis and lead to 
functional anchorage of initiated cells; and (c) the need to 
use other transcriptional regulatory elements to direct pro- 
duction of these oncoproteins to crypt epithelial cell popula- 
tions: specifically the functionally anchored stem cell or one 
of its immediate descendants (17). With these thoughts in 
mind, we generated several additional lines of transgenic 
mice to determine the consequences of initiating K-ras  v'~2 
production in the crypt. 
Analysis of I-FABP  -Is~ ~ +2a and L-FABP  -~ ~ +21/K-rasV°UZ 
Mice.  Removal  of  nucleotides  -1178  to  -185  from 
I.FABP-H~8 to  +28/reporte  r  transgenes  does  not  affect de- 
velopmental, cell lineage-specific, or cephalocaudal patterns 
of reporter production (15). However, precocious activation 
of transgene  expression occurs  in  proliferating and non- 
proliferating cells located in the middle and upper thirds of 
duodenal, jejunal, ileal, and proximal colonic crypts (15). 
Expression is sustained in members of the enterocytic lin- 
eage as they complete their migration from the crypt to the 
apical extrusion zones of villi. Nucleotides -596 to +21 of 
the homologous rat liver fatty acid binding protein gane can 
also be used to direct foreign gene expression to proliferating 
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proximal,  and  distal  colonic  crypts  (69,  75).  However, 
reporter production is initiated in the lower third of crypts, 
closer to the presumed stem cell zone than is observed with 
I_FABP-I~  ,o +2s (69).  Moreover, L-FABP  -5~s to +21/reporte  r 
transgenes are expressed in all four gut epithelial cell line- 
ages as they migrate along the crypt-villus (and -surface epi- 
thelial cuff) axis (61,  78).  L-FABP  -5~s ~ +21/reporter trans- 
genes are activated at the same time in fetal development 
as I-FABP  -"Ts ~ +28/reporter and I-FABP  -I~ to +2S/reporte  r 
transgenes (E15/E16)  and expression is maintained at con- 
stant levels in small intestine, proximal colon, hepatocytes, 
and proximal renal tubular epithelial cells during the first 
6-9 mo of life (14, 69). In contrast, I-FABP  -ls4 to +2s expres- 
sion decreases several fold during the weaning period (15). 
We chose to examine the effects of K-ras  w'12 in the crypt 
in view of  previous conclusions that ras-mediated alterations 
in the differentiation programs of other epithelial cell line- 
ages requires a proliferating population of target cells (2, 3, 
47). Three lines of I-FABP  -lu to +ZS/K_rasV,,2 mice were es- 
tablished (Table I). None of the transgenic mice belonging 
to these pedigrees appeared to have any abnormalities in the 
proliferation and differentiation  programs of  their gut epithe- 
lial cells at 4-8  wk of age (data not shown).  Subsequent 
ribonuclease protection studies of small intestinal and co- 
Ionic RNA  prepared  from  1-d-old  animals  indicated that 
only members of pedigree 65  contain detectable levels of 
K-ras  w't2 mRNA. By postnatal day 10 (P10), the concentra- 
tion of this mRNA falls markedly to the point where it is 
barely detectable. Neither P1 nor P10 mice belonging to line 
65 have demonstrable phenotypic abnormalities in their gut 
epithelium when compared  to  their  nontransgenic  litter- 
mates.  Thus,  progressive  extinction of I-FABP  -1s4  to  +~s/ 
reporter expression limits its usefulness in exploring the con- 
sequences of K-ras  v'.12 expression in proliferating and non- 
proliferating crypt epithelial cells. 
Two pedigrees  of L-FABP  -596  to +21/K_rasV,12 transgenic 
mice were also studied (Table I).  The founders, (3039 and 
44, became moribund at 15 and 13 wk of age, respectively. 
Biochemical analysis of their serum obtained at the time of 
sacrifice indicated that they were suffering from renal failure 
([blood urea nitrogen] >10 times normal) and had hepatocel- 
lular damage without cholestasis (alanine aminotransferase 
and aspartate  aminotransferase activities were  >20  times 
normal  while  alkaline phosphatase  activity and bilirubin 
concentration were within normal limits). Their kidneys ap- 
peared pale, nodular, and slightly enlarged. Multiple prox- 
imal tubular epithelial cells in S-phase were readily apparent 
in these animals (Fig. 6 A) but not in their comparably aged 
normal  littermates.  The  proximal  tubules  and  collecting 
ducts were markedly dilated. Glomerulosclerosis was evi- 
dent (Fig. 6 B). The liver was enlarged three fold in both 
founders. There were mild dysplastic changes in hepatocytes 
(Fig.  6  C).  Scattered  members  of this  lineage  were  in 
S-phase  (Fig.  6  D).  In  contrast,  there  were  no apparent 
proliferative abnormalities in the gut epithelium. BrdUrd- 
positive ceils were restricted to the crypt and crypt-villus ar- 
chitecture appeared entirely normal (Fig. 6 E).  Moreover, 
there were no detectable perturbations in the morphology or 
differentiation programs of the four principal gut epithelial 
cell lineages (for example see Fig. 6 F). The transgenic prog- 
eny of (3039 and 44 became moribund by postnatal week 
8-12 and exhibited histopathologic changes in their liver and 
kidney which were indistinguishable from those noted in 
their transgenic parents. Their small intestinal and colonic 
epithelium appear normal. Ribonuclease protection studies 
confirmed that the expression domain of L-FABP  -s96 to +2t/ 
K-ras  v~l~ along the cephalocaudal axis of the gut resembled 
that of other L-FABP  -59~ ~ +21/reporter transgenes (69, 75). 
The inability of K-ras  w'l~ to produce detectable changes 
in the biological properties of proliferating crypt epithelial 
cells or in the differentiation programs of their enterocytic, 
goblet, Paneth, or enteroendocrine cell descendants, con- 
trasts with the sensitivity of the hepatocyte and renal tubular 
epithelial cell lineages to this (or other) mutant ras protein 
(see reference 64). The apparent resistance of proliferating 
and  nonproliferating gut  epithelial  cell  populations  may 
reflect (a) the absence of signaling pathways which can be 
perturbed by K-ras  v~12, (b)  the presence of gene products 
which  oppose  K-rasV~l~-mediated  changes  in  prolifera- 
tion/differentiation (e.g., p53), and/or (c) the inability of ini- 
tiated, K-rasV~12-producing crypt (and villus) cells to be re- 
tained for a  sufficient period so that this oncoprotein can 
produce detectable effects-either by itself or after the acqui- 
sition of additional somatic mutations. Possibilities b and c 
can be explored by mating mice containing L-FABP  -59~ ~ +21/ 
K-ras  v~t2 to  mice  containing  L-FABP  -596  to  +21  linked  to 
other oncogenes (e.g., SV-40 TAg and its mutant derivatives) 
or to mice that are homozygous for p53 null alleles. 
Analysis of  Min/  + Mice That Carry One or More Trans- 
genes.  As  noted above,  APC mutations apparently occur 
early in the multistep journey to human colorectal neoplasia 
and  are  thought  to  be  important  for  initiation  (59).  A 
Leu---Stop mutation in codon 850 of  the C57B1/6 mouse Apc 
gene is associated with the development of  multiple intestinal 
adenomas (55,  56, 72).  C57B1/6 Min/+ mice first develop 
adenomas during the fifth postnatal week.  100-120-d-old 
animals exhibit striking differences in the number of tumors 
along their duodenal-colonic axis with highest concentra- 
tions present in the distal jejunum and ileum (Fig. 7 A). Ade- 
nomas are rarely found in the colon  s (Fig. 7 A).  This re- 
gional variation in tumor number contrasts with the constant 
levels of Apc and Apc  Mi. mRNAs from the stomach to the 
distal colon (Fig. 7 B). Min/+ mice generally die by postna- 
tal day 140 from anemia due to persistent intestinal bleeding 
(Fig. 7 C). We found that Min adenomas contain small foci 
of differentiated enterocytes, Paneth, goblet, and enteroen- 
docrine cells (56).  Expression of endogenous marker genes 
in these differentiated cells is appropriate for the position 
that these lineages occupy along the duodenal-colonic axis. 
The presence of  multiple lineages/adenoma, each with an ap- 
propriate "positional address" suggests that tumorigenesis in 
Min/+ mice may be initiated through a stochastic process in 
2. Intestinal tumors are observed in animals as young as 5 wk of age in the 
colony of B6 Min/+ mice maintained in Madison. The average number of 
tumors for  100-120-d-old animals in this colony is 24  +  7  for the small 
intestine and 5  +  4  for the colon using the scoring method described by 
Moser et al. (55). The highest number of adenomas occur in the proximal 
small bowel (55, 56). Mice rederived and maintained in St. Louis develop 
fewer tumors at 100-120 d of age: 17 +  6 in small intestine; 4  +  2 in colon 
using the scoring method of Moser et al. (55). The highest concentrations 
of adenomas occur in the distal jejunum and ileum. These colonies differ 
with respect to viral status and diet. The factors responsible for these ob- 
served differences in Min phenotype have not yet been identified. 
Kim et al.  Transgenic Mouse Models of Intestinal Neoplasia  887 Figure 6.  Analysis of 10-12-wk-old  L-FABP  -59~ to +21/K.rasVa112 transgenic  mice.  (A) Section  of kidney showing  several  BrdUrd-labeled 
cells  in the proximal tubular epithelium  (detected  with goat anti-BrdUrd serum and IGSS; arrows). Many tubules  and collecting ducts 
are grossly dilated and filled with proteinaceous material.  Moderate interstitial  fibrosis and focal chronic inflammation  are present.  There 
is no evidence of significant dysplasia.  (B) A sclerotic glomerulus is indicated by the arrow. Glomeruli show varying degrees of sclerosis, 
from minor segmental damage to diffuse hyalinization.  (C and D) Hematoxylin- and eosin-stained sections of liver show a hypercellular 
parenchyma. Hepatoeytes exhibit  increased nuclear-cytoplasmic ratios,  decreased cytoplasmic glycogen, increased nuclear atypia, and 
moderate pleomorphism (C). BrdUrd staining in D reveals scattered cells in S-phase (indicated by a closed arrow) as well as small clusters 
of proliferating  hepatocytes (open arrow). No frankly neoplastic  foci are evident.  (E and F) Sections of proximal jejunum show no obvious 
proliferative  abnormalities.  Double labeling  of the  section in E  with  rabbit anti-L-FABP and goat anti-BrdUrd  sera  (detected  with 
fluorescein-labeled  donkey anti-rabbit and Cy3-1abeled donkey anti-goat antibodies,  respectively)  demonstrates that BrdUrd positive cells 
(orange) are restricted  to crypt while L-FABP (green) is confined to villus-associated  enterocytes.  High power view of intestinal  villi  in 
F  shows normal appearing enterocytes and goblet cells.  No villus-associated  epithelial  cells  are seen in M-phase.  Bars,  25/zm. 
the  multipotent  crypt  stem  cell  or  one  of its  immediate 
descendants  (56). 
Min adenomas do not progress unless mice are crossed to 
other  strains  (e.g.,  AKR/J  or  MA/MyJ)  that  contain  un- 
linked modifier alleles. The resulting hybrid mice have fewer 
tumors, a longer lifespan (up to 300 d), and develop foci of 
adenocarcinoma in their adenomas late in life- likely reflect- 
ing the acquisition of additional somatic mutations required 
for progression (e.g.,  loss of heterozygosity). 
We introduced Min into the genomes of our FVB/N trans- 
The Journal of Cell Biology, Volume 123, 1993  888 Figure 7. Effect of I-FABP  -1178  to +2S/oncogen  e transgenes on the number and distribution of intestinal adenomas in Min/+ mice. The num- 
ber of adenomas was determined along the cephalocaudal  axis of the gut in 100-120-d-old  mice using procedures  described in Materials 
and Methods.  The number of mice surveyed is indicated in parentheses.  B shows the distribution of Apc and Apc  M~n mRNAs along the 
cephalocaudal  axis of the imestine of normal FVB/N and C57B1/6 Min/+  mice as determined by a ribonuclease protection assay (see 
Materials and Methods).  Additional abbreviations used include: BR, brain; ytRNA, yeast tRNA. The positions of migration of MspI DNA 
fragments derived from pBR322 are shown to the right of the figure. (C) Hematocrits were determined on samples of blood recovered 
by retro-orbital phlebotomy at various ages (n =  14 C57B1/6 mice; 20 C57B1/6 Min/+  mice; and fourteen C57B1/6 Min/+  X FVB/N 
animals). (D-H) Effect of I-FABP  -1178 to +28/oncogen  e transgenes on tumor number in 100-120-d-old  mice that carry Min. The Journal of Cell Biology, Volume  123, 1993  890 genic mice to assess the role of its protein product on entero- 
cytic proliferation, migration, and differentiation programs 
and to determine if it could cause progression of the dyspla- 
sia encountered  in  initiated,  villus-associated enterocytes. 
An  initial  control  experiment confirmed that Min  is fully 
penetrant in FVB/N X C57B1/6 Min/+  mice. However, the 
number of tumors is at least an order of magnitude lower in 
their  distal jejunum  and  ileum (Fig.  7  A),  suggesting the 
presence of at least one modifier allele in the FVB/N genome 
(but not necessarily the same one as in AKR or MA). The 
cephalocaudal variation in tumor number observed in these 
hybrid mice resembles the variation noted in their C57B1/6 
Min/+  parent  (Fig.  7  A).  The reduction  in overall tumor 
number is associated with a reduction in intestinal blood loss 
and increased lifespan (to >200 d; see Fig. 7 C). The intesti- 
nal adenomas of 90-180-d-old FVB/N X  Min/+  C57B1/6 
hybrids have the same histological features as the adenomas 
of  comparably  aged  Min/+  C57B1/6  animals  (data  not 
shown). 
Min/+  C57B1/6 mice were crossed to members of SV-40 
TAg line  103 or K-ras  wt12 line 73 or p53 Ala143 line 14.  They 
were also mated to mice carrying two transgenes  (G0103 
SV-40 TAg X  G073  K-rasV~'~2), and to mice carrying three 
transgenes  (G0103  SV-40  TAg  X  G073  K-ras  w~2  X  G014 
p53Al~143). Animals from each cross (n  =  1-4) were sacri- 
ficed between postnatal days 100 and 120. The epithelium lo- 
cated between intestinal neoplasms appeared similar to the 
epithelium  of  the  parental  single  transgene-containing, 
bi-transgenic, or tri-transgenic mice without Min (e.g., com- 
pare Fig.  8, A-C with Fig. 3 A). There are several possible 
explanations for the failure of Min to produce progression of 
the dysplasia noted in SV-40 TAg/K-ras  v~12 positive entero- 
cytes. First, the expression of domains of Min and the trans- 
genes may not overlap along the crypt-villus axis, e.g., Apc 
and Apc  M~° may be confined to the crypt or not expressed in 
enterocytes. Second, the dysplastic changes induced by SV- 
40 TAg and K-ras  v~"2 may repress Apc/Apc  Mi° expression in 
villus-associated enterocytes.  Third,  the residence time of 
these villus-associated cells may be too short for the mutant 
protein to exert its effect(s). Fourth,  the villus' enterocytic 
population may not possess the metabolic machinery neces- 
sary to support whatever further changes this mutant protein 
could potentially produce in their proliferation/differentia- 
tion programs. 
No significant increase in average tumor numbers occurs 
in Min X  K-ras  va"2 or Min X  p53 Alat43 mice (control group 
=  comparably aged  FVB/N  X  Min/+  C57B1/6  animals 
housed under identical conditions; Fig. 7, D and E). When 
Min  is  introduced  into  the  genomes  of  mice  carrying 
I-FABP  -tin '° ~28/SV-40 TAg, or into the genomes of the bi- 
transgenic  and  tri-transgenic  animals,  tumor  number  in- 
creases 2-3-fold in the distal jejunum and ileum and 2-5-fold 
in the duodenum/proximal jejunum. No significant changes 
are detectable in the cecum or colon (Fig. 7, F-H). Remark- 
ably, the distribution of tumors along the duodenal-colonic 
axis is similar to the distribution in mice with Min alone. 
The phenotypes of intestinal adenomas in 100-120-d-old 
Min  X  K-ras  v''12 or Min  X  p53  Ala143 or Min  X  SV-40 TAg 
mice are indistinguishable from the phenotypes of adenomas 
in control 100-120-d-old FVB/N X C57B1/6 Min/+ animals 
(data not shown). The phenotypes of adenomas in 100-120- 
d-old Min X SV-40 TAg X K-ras  v~2 mice and Min X SV-40 
TAg X  K-ras  v~t2 X  p53 Al~a3 mice (e.g.,  Fig.  8,  D-F) are 
also similar to the phenotype of adenomas in control hybrid 
animals.  Tumors in mice carrying I-FABP  -H78 to +28/SV_40 
TAg do  not have detectable levels of SV-40 TAg in their 
proliferating and nonproliferating cell populations (Fig.  8, 
G-L), suggesting that the degree of differentiation of these 
cells is not sufficient to allow I-FABP  -H78 '° +28 to function. 
The  observation  that  I-FABP  -"Ts  '° ÷2s/SV-40 TAg plus 
I-FABP  -"Ts t° +28/K-ras  wt2 only produce a small increase in 
the number of jejunal/ileal adenomas provides independent 
support for the hypothesis that initiation of tumorigenesis in 
Min  mice is  a  stochastic  event which  typically occurs  in 
crypts rather than in villus-associated epithelial cell popula- 
tions.  Since  Apc/Apc  M~ mRNA levels are constant  along 
the cephalocaudal axis of the gut, the observed modest in- 
crease  in  tumor  number  without  a  change  in  their  duo- 
denal-colonic distribution is consistent with the notion that 
initiated  cells in Min/+  mice must acquire additional  so- 
matic mutations to progress to adenomas and that cells lo- 
cated in the distal half of the mouse small intestine are more 
vulnerable to these mutations than those in the colon. The 
dysplastic epithelium of our bi-transgenic and tri-transgenic 
mice may contribute to this enhanced vulnerability and/or to 
help promote progression during the early stages of tumori- 
genesis.  The absence of detectable progression in  Min  X 
transgene adenomas once they form may be due to the fact 
that their poorly differentiated cellular populations are un- 
able to support I-FABP  -H78 ~° ÷:S-mediated  transcription  of 
Figure 8. Analysis of the effect of I-FABP  -HTat°  +28/oncogene transgenes on the gut epithelium of Min/+mice.  (A-C) 120-d-old mouse car- 
rying I-FABP/SV-40 TAg +  I-FABP/K-ras  w12 +  I-FABP/p53  Ajar43 and Min. SV-40 TAg (detected as aqua-colored material using rabbit 
anti-SV-40 TAg serum, gold-labeled donkey anti-rabbit antibodies, and silver intensification staining) is present in both crypt and villus- 
associated epithelial cells (A). Re-entry of villus-associated enterocytes into the cell cycle is indicated in B by the numerous red-appearing 
BrdUrd-labeled cells (detected with goat anti-BrdUrd serum and Texas red-labeled second antibodies). Double exposure clearly illustrates 
the presence of BrdUrd and SV-40 TAg in the orange-colored nuclei of villus-associated enterocytes. (D) Hematoxylin and eosin stained 
section of  jejunum demonstrates an adenoma (arrow) arising within the hyperplastic and dysplastic intestinal epithelium typical of a 120-d- 
old mouse carrying Min plus the three transgenes. (E and F) Higher magnification views of hematoxylin and eosin-stained jejunal sections 
prepared  from the mouse shown in D demonstrate  that the adenoma is composed of cells which are more dysplastic than those which 
populate the epithelium located between tumors.  (G-L) I-FABP  -lm to +2s/does not function in the poorly differentiated cells of an ade- 
noma present  in a Min/+  X SV-40 TAg X K-ras  v~2 X p53  ^lat43 mouse.  G and J  show frequent BrdUrd-labeled  cells in both adenomas 
(arrows) and in the intervening non-adenomatous  epithelium.  H and K show numerous SV-40 TAg-labeled nuclei in non-adenomatous 
villus epithelium and only rare, weakly stained nuclei in the adenomas. Dual exposure in 1 and L demonstrates the relationship between 
SV-40 TAg expression and BrdUrd labeling in non-adenomatous epithelium. The ability of this epithelium to support production of SV-40 
TAg in its proliferating and nonproliferating cell populations contrasts with the lack of detectable  SV-40 TAg in the adjacent adenoma. 
Bars:  (A and G) 50/~m; (D)  100 #m; (E and J) 25 #m. 
Kim et al. Transgenic Mouse Models of Intestinal Neoplasia  891 oncogenes (Fig.  8,  G-L).  In contrast, L-FABP  -sg~ ~ +27 may 
support reporter production in Min adenomas. If so, cross- 
ing Min mice to transgenic animals containing one or more 
L-FABP  -sg~  ~ +21/oncogene DNAs may allow reconstitution 
of  a multistep process that  ultimately  leads to development 
of intestinal  adenocarcinoma. 
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